Nasdaq
華爾街日報QUEBEC, Dec. 19, 2025 /PRNewswire/ - Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD) (OTCQB: DVHGF), a biopharmaceutical Company specializing in the development of prescription drugs targeting inflammatory diseases today announced the grant of Stock Options.
Read more at prnewswire.comDevonian Health Group Announces Grant of Stock Options
Barchart·12/19/2025 08:15:00
語音播報
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.